Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Pancreas ; 39(6): 847-55, 2010 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-20697208

RESUMO

OBJECTIVES: We investigated the influence of leucine supplementation on insulin secretion and on some proteins related to insulin secretion in malnourished mice. METHODS: Swiss mice (aged 21 days) received isocaloric normo-17% (NP) or 6% low-protein (LP) diet for 120 days. Half of the NP and LP mice received 1.5% leucine in the drinking water during the last 30 days (NPL and LPL, respectively). RESULTS: The LP mice were hypoinsulinemic compared with the NP group, whereas LPL mice exhibited increased insulinemia in the fed state versus LP mice. The LP mouse islets were less responsive to 22.2 mM glucose, 100 microM carbachol (Cch), and 10 mM leucine than the NP group. However, LPL islets were more responsive to all these conditions compared with the LP group. The muscarinic type 3 receptor, (M3R) Cabeta2, and PKC-alpha protein contents were reduced in LP compared with NP islets but significantly higher in LPL than LP islets. The p-AKT/AKT ratio was higher in LPL compared with LP islets. CONCLUSIONS: Leucine supplementation increases insulin secretion in response to glucose and leucine and to agents that potentiate secretion, such as Cch, in malnourished mice. The enhanced levels of M3R, Cabeta2, and PKC-alpha proteins, as well as of the p-AKT/AKT ratio, may play a role in this process.


Assuntos
Suplementos Nutricionais , Insulina/metabolismo , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/metabolismo , Leucina/administração & dosagem , Desnutrição/tratamento farmacológico , Albuminas/análise , Animais , Glicemia/efeitos dos fármacos , Peso Corporal , Canais de Cálcio Tipo L/análise , Carbacol/farmacologia , Colesterol/sangue , Dieta com Restrição de Proteínas , Ácidos Graxos não Esterificados/sangue , Glucose/metabolismo , Glucose/fisiologia , Insulina/sangue , Secreção de Insulina , Desnutrição/metabolismo , Camundongos , Proteína Quinase C/análise , Proteínas Serina-Treonina Quinases/análise , Receptor Muscarínico M3/análise , Triglicerídeos/sangue
2.
Auton Autacoid Pharmacol ; 26(3): 293-301, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16879495

RESUMO

1 The aim of the present work was to examine the role of muscarinic acetylcholine receptors (mAChR) on DNA synthesis and CD40 expression in human fibroblast cells. Neonatal human skin fibroblast cultures were stimulated with carbachol in presence or absence of specific antagonists and the following parameters were measured: identification of mAChR subtypes, DNA synthesis, inositol phosphates (InsP) production and CD40 expression. 2 Human fibroblasts express mAChR with Kd 0.47 +/- 0.11 nm and Bmax 236 +/- 22 fmol mg protein(-1). Carbachol stimulates DNA synthesis, InsP and the expression of CD40. All these effects were inhibited by atropine, mustard hydrochloride (4-DAMP) and pirenzepine but not by AF-DX 116 and tropicamide, indicating that M3 and M1 mAChR are implicated in carbachol action. The relative Ki of the antagonists obtained by competition binding assay was in parallel to the relative potency for blocking both carbachol-stimulated InsP accumulation and DNA synthesis. 3 The intracellular pathway leading to carbachol-induced biological effects involved phospholipase C and calcium/calmodulin, as U-73122 and trifluoroperazine blocked carbachol effects, respectively. Calphostin C, a protein kinase C inhibitor, had no effect, indicating that this enzyme does not participate in the system. 4 These results may contribute to a better understanding of the modulatory role of the parasympathetic muscarinic system on normal human fibroblast function.


Assuntos
Antígenos CD40/biossíntese , DNA/biossíntese , Fibroblastos/efeitos dos fármacos , Agonistas Muscarínicos/farmacologia , Receptores Muscarínicos/efeitos dos fármacos , Atropina/farmacologia , Calmodulina/antagonistas & inibidores , Calmodulina/metabolismo , Carbacol/farmacologia , Células Cultivadas , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Estrenos/farmacologia , Fibroblastos/imunologia , Fibroblastos/metabolismo , Citometria de Fluxo , Humanos , Fosfatos de Inositol/metabolismo , Antagonistas Muscarínicos/farmacologia , Pirenzepina/farmacologia , Pirrolidinonas/farmacologia , Quinuclidinil Benzilato , Ensaio Radioligante , Receptor Muscarínico M1/análise , Receptor Muscarínico M1/efeitos dos fármacos , Receptor Muscarínico M1/metabolismo , Receptor Muscarínico M3/análise , Receptor Muscarínico M3/efeitos dos fármacos , Receptor Muscarínico M3/metabolismo , Receptores Muscarínicos/análise , Receptores Muscarínicos/metabolismo , Trifluoperazina/farmacologia , Fosfolipases Tipo C/antagonistas & inibidores , Fosfolipases Tipo C/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA